Main Article Content

Abstract

This is a prospective observational study done for a period of three years from March 2015 to March 2015 at the inpatient block of multispecialty hospitals, Patients Visited or admitted in Hospital due to ADRs Hyderabad, Patients who visited the Hospital were reviewed on daily basis and monitored for ADRs. Patient’s demographic details are collected and documented. Suspected ADRs were assessed by using standard algorithms. It includes all the information such as name, age, sex, reason for admission, brief description of reaction, relevant past history of medication, the onset and severity of the ADR experienced the impact of ADR on the treatment and drug involved, dose of the drug, route and frequency time. All the suspected ADRs were evaluated for their causality using WHO Probability Scale, Naranjo’s Algorithm, and the Karch and Lasagna scale Severity assessment was done using the Hartwig et al. Scale. Preventability of an ADR is determined by using Shumock et al. criteria. Predictability of an ADR is also determined by using criteria’s. Results and Discussion: Among the 383 cases, 592 adverse drug reactions were identified, which shows the probability of multiple adverse drug reactions in a single patient. Among age groups adults 52.74% were predominant over geriatric 36.55% and children 10.70% in terms of prevalence, while males have higher risk to develop adverse drug reactions among adults and geriatrics, and in Children both the genders have high risk in developing adverse drug reactions and showing 1.69 times higher risk for males to develop adverse drug reactions. Among the 383 cases documented predominance of adverse drug reactions was observed in patients belonging to urban area 59.26%.

Keywords

Adverse drug reaction Dermatology gastrointestinal suspected drug.

Article Details

How to Cite
Shete Shivkumar Kashinath, & Dr. K. Sattanathan. (2021). Management of the ADRs experienced during the Hospital stay. International Journal of Research in Pharmacology & Pharmacotherapeutics, 10(4), 303-307. https://doi.org/10.61096/ijrpp.v10.iss4.2021.303-307

References

  1. 1. Abdela OA, Bhagavathulu AS, Getachew H, Keliya Y.Risk factors for developing drug related problems in patient with cardiovascular diseases attending Gondar University Hospital, Ethopia.J Pharm Bioallied Sci.2016 Oct-Dec;8(4):289-295.
  2. 2. An Introduction to Pharmacovigilance. By Patrick Waller. Published 2010 by Blackwell Publishing, ISBN: 978-1-4051-9471-6. Page no 2
  3. 3. Acheampong F, et al. Drug related problems and their clinical interventions in a ghanan teaching.Safety in Health.2016;2:15
  4. 4. Adusumilli PK, Adepu R. Drug related problems: An overview of various classification systems. Asian J Pharm Clin Res.2014 May 16; 7(4):8-10.
  5. 5. Agu KA, Oparah AC. Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria. Adverse Perspect Clin Res 2013;4(2):117-24. [http://doi:10.4103/2229-3485.111784] [PMID: 23833736]
  6. 6. Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z.A systematic review of hospitalization result in from medicine –related problems in adult patients.Br J Clin Pharmacol.2013 Nov 28;78(2):202-17.
  7. 7. Al-Ariti M, Abu-Hashem H, Al-Mezing M, Said R, Aljadhey H.Emergency department visits and admissions due to drug related problems at Riyadh Military Hospital(RMH), Saudi Arabia. Saudi Pharm J.2014 Jan;22(1):17-25.
  8. 8. Alghamdy MS, Randhawa MA, Al-Wahhas MH and Al-Jumaan MA. Admissions for drug related problems at the emergency department of university hospital in the kingdom of Saudi Arabia. J Family Community Med.2015Jan-Apr[cited2017Aug11];22(1):44-48. Availablefrom:https://www.ncbi.nlm.nih.gov/m/pubmed/25657611/DOI:10.1177/0363546512458223
  9. 9. Alumran A, Hou XY, Hurst C. Assessing the overuse of antibiotics in children in Saudi Arabia: Validation of parenteral perception on antibiotics scale(PAPA Scale). Health Qual Life Outcomes. 2013 Mar 11; 11:39.
  10. 10. Aronson JK, Ferner RE. Classification of terminology in drug safety. Drug Safety 2005; 28: 851-870.
  11. 11. Amer Khan .Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care HospitalJournal of Basic Clin Pharm. June 2015-August 2015; 6(3): 84–88. doi: 10.4103/0976-0105.160744
  12. 12. American Society of Health System Pharmacists. Top- Priority Actions for Preventing Adverse Drug Events in Hospitals: “Recommendations of An Ex9. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2006;16:223–8. pert Panel.”. Am. J. Health-Syst. Pharm. 1996,53, 747-751.
  13. 13. American Association of retired person. US: Gregory P; 2017 Oct 1. Medication Administration: why it’s important to take drugs the right way.27 Oct 1[cited on 2017 Dec 28]. Available from https://www.aarpmedicareplans.com/hea lth/ administration of medication.
  14. 14. Andreazza RS, Castro MSD, Koche PS, Heineck I. Causes of drug-related problems in the emergency room of a hospital in southern Brazil. Gac Sanit.2011 Nov-DEC;25(6):501-6.
  15. 15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC 4310971/#_ffn_sectitle. DOI:10.1016/j.jsps.2013.05.006
  16. 16. Barrins-associatES{internet].US : Barrins Associates:2016.Medication ordering and therapeutic duplication.2016 Aug 16[cited 2017 Dec 27]; Available from : http://barrins-assoc.com/resources/compliance-updates/medication-ordering-therapeutic-duplication-psychiatric-hospitals/
  17. 17. Basharat S, Asmat S, Dr. Zaka M. Management of drug related hospital admissions. ISSN.2016 Nov;6(11):2250-3153.
  18. 18. Batel Marques F, A systematic review of observational studies evaluating costs of adverse drug reactions. Clinicoecon Outcomes Res. 2016 Aug 24;8:413-26. doi: 10.2147/CEOR.S115689. eCollection 2016.
  19. 19. Bennett PN, Brown MJ. Clinical Pharmacology. Tenth edition. Churchill Livingstone, Edinburgh, 2008.
  20. 20. Beijer HJM and Blaey CJD. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.Pharm World sci.2002 Apr [2017 Jul 28];24(2):46 54. Available from: https://www.ncbi.nlm. nih.gov/m/pubmed /1206 1133/
  21. 21. Belongia EA, et al. strategies for promoting judicious use of antibiotics by doctors and patients. BMJ. 2000 Sep 23; 321(7263):765